MedTrace Logo

A Community of Practice Program With Psilocybin-assisted Therapy for End-of-Life Patients

NCT05958758 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2023-07-25

No results posted yet for this study

Summary

The purpose of the study is to understand the feasibility of a resilience focused community of practice program that includes psilocybin-assisted therapy for End-of-Life Distress. The community of practice refers to a research informed group therapy process that runs over a 10-week period of time and includes one group administered psilocybin-assisted therapy session.

Target population: The treatment team will treat a total of 64 patients who have:

* a terminal diagnosis (experiencing end of life distress),
* AND who are eligible for the RTT + Psilocybin-assisted Therapy Treatment program through the RTT Society.

Conditions

  • End of Life

Interventions

DRUG

Psilocybin-assisted therapy within a community of practice model (group administered)

The community of practice is 10 weeks long, meeting virtually for 2 hours each week, in a structured process, run through the Roots to Thrive treatment program. The psilocybin-assited therapy sessions occur midway through the 10-week program.

Sponsors & Collaborators

  • Vancouver Island Health Authority

    collaborator OTHER

  • Vancouver Island University

    collaborator UNKNOWN

  • The Roots to Thrive Society for Psychedelic Therapy

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-04-30
Completion
2025-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05958758 on ClinicalTrials.gov